Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer.

Emancipator K, Huang L, Aurora-Garg D, Bal T, Cohen EEW, Harrington K, Soulières D, Le Tourneau C, Licitra L, Burtness B, Swaby R. Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer. Mod Pathol. 2020 Nov 25.

View in: PubMed

collapse authors with profiles